Amy Jo Jenkins was named director of the Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration and will lead early phase clinical trials at the University of Arkansas for Medical Sciences.
Jenkins will direct early phase clinical research, including operations, staffing, trial management and execution, and business development. She will also work to improve the effectiveness of executing cancer-related research contracts and filings in partnership with other institutional offices.
Her other duties include creating and managing a quality assurance and control program within the Cancer Institute’s research efforts, and developing and maintaining standard operating procedures. She will also oversee the UAMS Winthrop P. Rockefeller Cancer Institute Network, which includes the UAMS Regional Campuses, the UAMS/Baptist Health joint venture and the Cancer Institute’s partner practices throughout Arkansas. Jenkins will identify and use opportunities to develop and expand clinical trial participation throughout the network.
Jenkins was previously chief of staff in the office of Chancellor Cam Patterson, and CEO of UAMS Health. Prior to that, Jenkins was executive director of the Translational Research Institute from 2016 to 2020, providing oversight and leadership of the institute’s daily operations. She joined TRI in 2014 as a senior project manager. She has also taught courses through the UAMS colleges of Public Health and Pharmacy as part of a program in regulatory sciences since 2012.
She first joined UAMS in 2009 as clinical research monitoring manager.
